CDKN2A and uterine cervix neoplasm: Along with the detection of p16ink4a expression in the majority of the HR-HPV-positive cervical tumors, hypermethylation of p16 INK4a promoter has been demonstrated in 25–57% of cervical carcinomas by methylation-specific PCR, MSP [22-27].